Related Experiment Videos

Demonstration of bias in series of retinoblastoma

M Jay1, J K Cowell, J E Kingston

  • 1Institute of Opthalmology, University of London, UK.

Insights

A UK registry aims to track all retinoblastoma cases. The hospital series is complete but biased, showing more bilateral retinoblastoma than the general population.

Area of Science:

  • Ophthalmology
  • Oncology
  • Epidemiology

Background:

  • Retinoblastoma is a rare pediatric eye cancer.
  • Accurate incidence data is crucial for understanding disease burden and planning services.
  • Previous data may lack complete ascertainment across the United Kingdom.

Purpose of the Study:

  • To establish a comprehensive national registry for retinoblastoma in the UK.
  • To achieve complete ascertainment of all diagnosed retinoblastoma cases.
  • To analyze the characteristics of retinoblastoma cases, including laterality.

Main Methods:

  • Compiling a register of retinoblastoma cases across the United Kingdom.
  • Utilizing multiple sources for case ascertainment: hospital records, regional cancer registries, and pathology reports.
  • Comparing case proportions (bilateral vs. unilateral) between a specific hospital series and national data.

Main Results:

  • Ascertainment is complete for cases from St Bartholomew's and Moorfields Eye Hospitals.
  • National ascertainment for retinoblastoma remains incomplete.
  • The hospital series shows a higher proportion of bilateral retinoblastoma compared to the country as a whole, indicating a potential bias.

Conclusions:

  • A UK retinoblastoma registry is in development, with ongoing efforts to improve national case ascertainment.
  • The hospital series provides valuable, though potentially biased, data on retinoblastoma laterality.
  • Further research is needed to address ascertainment gaps and confirm national epidemiological trends.

Related Concept Videos